Viewing nowCombinationXone Tablet 5/160 mg
Valsartan 160mg · Amlodipine Adipate 6.79mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.

MFDS item code 201308288 · Approved 2013.07.18 · Insurance code 640006580
Treatment of essential hypertension inadequately controlled with monotherapy
This medication is used to effectively control blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or valsartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medicine may be considered as follows. ㆍ5/80mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or valsartan 80mg as monotherapy. ㆍ5/160mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or valsartan 160mg as monotherapy. ㆍ10/160mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg or valsartan 160mg as monotherapy, or with 5/160mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this medicine to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Use of this medicine is not recommended in pediatric patients under 18 years of age because safety and efficacy have not been established.
This drug can cause serious harm or death to the fetus and newborn if taken during the second or third trimester of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug's main ingredients or similar classes of drugs, pregnant women, those with severe kidney or liver dysfunction, or certain heart diseases should not take this medication. Patients with low sodium or fluids may experience hypotension, so it is important to check their condition before taking it, and closely monitor blood pressure and condition during treatment. If potassium levels are high or if taking other medications that may increase potassium, potassium levels should be checked frequently to ensure there are no abnormalities. Patients with narrowed renal arteries or those who have had kidney transplants may experience kidney issues while taking this medication, requiring special caution. If symptoms of angioedema, such as swelling of the face, lips, or tongue, occur, the medication should be stopped immediately and should not be taken again. Patients with heart failure or those who have had a myocardial infarction should have their kidney function and heart condition regularly checked while taking this medication. Patients with acute myocardial infarction or those with certain heart valve diseases should use this drug with caution. This medication is not recommended to be taken concurrently with other drugs acting on the renin-angiotensin-aldosterone system, as concomitant use may increase the risk of hypotension, worsening kidney function, and hyperkalemia. During treatment, symptoms such as dizziness and fatigue may occur, so care should be taken while driving or operating machinery. This drug may interact with other medications, so any concurrent medications should be discussed with a healthcare professional. Breastfeeding women are advised to avoid taking this medication, and its use in children is not recommended due to insufficient evidence for safety and efficacy. In cases of overdose, severe hypotension or reflex tachycardia may occur, so it is important to adhere strictly to the prescribed dosage and seek medical attention immediately if any abnormal symptoms arise.
Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, sweating, rash, itching, joint swelling, low back pain, arthritis, muscle spasms, weakness, polyuria, nocturia, erectile dysfunction, edema, angioedema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, elevated serum potassium, vasculitis, elevated liver function tests, vascular edema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, emotional changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, phototoxic reaction, vascular edema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorder, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, leukopenia, thrombocytopenia, confusion, exfoliative dermatitis, Stevens-Johnson syndrome, phototoxic reaction, toxic epidermal necrolysis
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is advisable to maintain the storage temperature at room temperature between 1 degree and 30 degrees Celsius.
Dark yellow oval-shaped film-coated tablet
30 tablets (10 tablets/PTP x 3), 30 tablets/bottle, 90 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Adipate 6.79mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationValsartan 160mg · Amlodipine Adipate 13.57mg
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationValsartan 80mg · Amlodipine Adipate 6.79mg
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.